ozaminod

Go or no go? Ozanimod and Fintepla await FDA verdicts
EP Vantage
Wed, 02/26/20 - 10:26 am
Bristol-Myers Squibb
ozaminod
MS
multiple sclerosis
Zogenix
Fintepla
FDA
Bloodied Celgene posts promising ozanimod PhIII MS data, but is it really a $6 billion drug?
Endpoints
Mon, 10/30/17 - 09:56 am
Celgene
ozaminod
MS
multiple sclerosis